IM-81

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameIM-81
Drug Alias NameIM-81
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsMesothelin
Therapy Area/IndicationsPancreatic NeoplasmsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImunopharm Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImunopharm Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A